Skip to content
Toggle main navigation
About
About TEPHINET
About TEPHIConnect
Terms of Use and Privacy
How to Join
Why Join?
News
Events
Groups
Journals
BMC Medicine
BMC Medical Research Methodology
Clinical Epidemiology and Global Health
Emerging Microbes & Infections
Frontiers in Epidemiology
Global Health Journal
International Journal of Epidemiology
Online Library Journal
PLoS One
Science Direct Journal (Global Health)
Science Direct Journal (Clinical Epidemiology and Global Health)
More
Open dropdown to see remaining menu items
Log in
Request to join
AFENET COVID-19 at a Glance # 152
Published on May 14, 2021
AFENET COVID-19 at a Glance
Issue #152
is now available
Other news
People with HIV are still dying from a treatable, but neglected, disease: cryptococcal meningitis
May 14, 2021
The real problem lies with with a lack of political will to address this leading cause of HIV-related mortality.In May 2021, a group of health organisations based in Africa, Europe and the US released the Strategic Framework for Ending Cryptococcal Meningitis Deaths by 2030. The Conversation
EARLY RELEASE: Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021
May 14, 2021
The first U.S. multisite test-negative design vaccine effectiveness study among HCP found a single dose of Pfizer-BioNTech or Moderna COVID-19 vaccines to be 82% effective against symptomatic COVID-19 and 2 doses to be 94% effective.